Non-DDX41 somatic variants were detected in 78.8% (26/33) of patients with germline DDX41 variants, including 84.6% of AML patients and 73.3% of MDS patients (p = 0.655). This evidence concerns the gene DDX41 and myelodysplastic syndrome.